114
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Federal procurement of unlicensed medicines in Brazil; findings and implications

, , , , , & show all
Pages 607-613 | Received 24 Nov 2016, Accepted 22 Mar 2017, Published online: 13 Apr 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Andres Freiberg & Jaime Espin. (2022) Towards a taxonomy of judicialisation for access to medicines in Latin America. Global Public Health 17:6, pages 912-925.
Read now

Articles from other publishers (4)

Lisiane Freitas Leal, Claudia Garcia Serpa Osorio-de-Castro, Luiz Júpiter Carneiro de Souza, Felipe Ferre, Daniel Marques Mota, Marcia Ito, Monique Elseviers, Elisangela da Costa Lima, Ivan Ricardo Zimmernan, Izabela Fulone, Monica Da Luz Carvalho-Soares & Luciane Cruz Lopes. (2022) Data Sources for Drug Utilization Research in Brazil—DUR-BRA Study. Frontiers in Pharmacology 12.
Crossref
Pollyanna Farias Castro Pereira de Lyra, Dyego Carlos Souza Anacleto de Araújo, Genival Araújo dos Santos Júnior, Bárbara Manuella Cardoso Sodré-Alves, Elisdete Maria Santos de Jesus, Divaldo Pereira de Lyra Jr. & Lucindo José Quintans Jr.. (2021) The quality of research on judicialization and its influence on public policies on access to medicines in Brazil: a systematic review. Ciência & Saúde Coletiva 26:11, pages 5577-5588.
Crossref
Ricardo Eccard da Silva, Elisangela da Costa Lima, Maria Rita C. G. Novaes & Claudia G. S. Osorio-de-Castro. (2020) The High “Cost” of Experimental Drugs Obtained Through Health Litigation in Brazil. Frontiers in Pharmacology 11.
Crossref
Marina M Garcia, Mariana M Barbosa, Rondineli M Silva, Edna A Reis, Juliana Alvares, Francisco de Assis Acurcio, Brian Godman & Augusto A Guerra Junior. (2019) Indicator of access to medicines in relation to the multiple dimensions of access. Journal of Comparative Effectiveness Research 8:12, pages 1027-1041.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.